OncologyConsults




Colorectal CME
CME Activities

Considerations for Use of Immune Therapy to Treat Metastatic Colorectal Cancer CME Credits: 0.5
Colorectal cancer (CRC) is a leading cause of cancer-related deaths with poor 5-year survival rates for patients with metastatic disease.
Faculty: Dung T. Le, MD Expires: 6/15/2019